21.12.2012 16:21:30

EANS-Adhoc: Hönle acquires Grafix

=------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =-------------------------------------------------------------------------------

Mergers - Acquisitions - Takeovers 21.12.2012

Gräfelfing, Munich, 21 December 2012

Today the Hönle Group signed the contract of purchase for the acquisition of all major assets of Grafix GmbH. The Grafix GmbH creditors' committee had already accepted Dr. Hönle AG's binding offer of 14 December 2012. The assets are being acquired by a wholly owned subsidiary of Dr. Hönle AG, which will continue Grafix GmbH's businesses under the latter's established name. Besides the fixed and current assets, including a business property at the Unterlüß site (Celle), the assets acquired also encompass the entire business activity of the insolvent Grafix GmbH. As already reported on 14.12.2012, the purchase price agreed was a low single-digit million amount.

The acquisition of the assets becomes effective in law from the beginning of January 2013.

Practically all the employees of Grafix GmbH not taken on by the Hönle Group have stated that they are prepared to switch to a newly founded employment and qualification company as of 01.01.2013. Because of the acquisition of the assets of Grafix GmbH the publication of the annual report of Dr. Hönle AG for the 2011/2012 financial year will be deferred from 14 January 2013 to 28 January 2013.

Stuttgart-based Grafix GmbH is a leading global producer of peripheral devices used in the colour fixing segment. The company's product program comprises drying and powder spraying systems, fountain solution & ink temperature control systems. Grafix supplies both printing firms and printing machine manufacturers with this product program. As an important supplier, Grafix has access to leading manufacturers of offset and digital printing machines worldwide. In addition, Grafix offers solutions for other sectors of industry such as the glass, plastics and pharmaceutical industries.

The company was founded in Stuttgart in 1947 and was extended by a second production site at Unterlüß in the year 2000. With approximately 100 employees, Grafix will generate revenues of about EUR 10 million in 2012. On 15 October 2012, Grafix GmbH filed a petition for preliminary insolvency proceedings.

Dr. Hönle AG assumes that the successor of Grafix GmbH will contribute positively to Hoenle Group earnings as early as in the 2012/2013 business year.

Additional information via Grafix GmbH: www.grafix-online.de

About Hönle: Dr. Hönle AG is a listed technology company with registered head office in Gräfelfing near Munich. With about 500 employees, the Hönle Group is among the leading suppliers in the UV technology segment worldwide. The equipment is used in colour and paint drying, in adhesives and plastics hardening and in surface sterilization and sunlight simulation. Adhesives and casting compounds for industrial applications are another focus of activities. Moreover, the corporate group manufactures UV beamers for water sterilization and produces tubes and semi-finished products from fused quartz for use in various sectors of industry. Worldwide, the Hönle Group is represented at ca. 50 locations in more than 20 countries with its own companies and distribution partners.

Contact: Dr. Hönle AG, Peter Weinert, Lochhamer Schlag 1, 82166 Gräfelfing/Munich, phone: 089-85608-173, peter.weinert@hoenle.de, www.hoenle.de

end of announcement euro adhoc =-------------------------------------------------------------------------------

(END) Dow Jones Newswires

   December 21, 2012 09:51 ET (14:51 GMT)- - 09 51 AM EST 12-21-12

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Dr. Hönle AG - UV Technologymehr Nachrichten

Analysen zu Dr. Hönle AG - UV Technologymehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Dr. Hönle AG - UV Technology 8,32 -0,72% Dr. Hönle AG - UV Technology

Indizes in diesem Artikel

Prime All Share 7 562,64 0,77%
CDAX 1 667,09 0,59%
Technology All Share 3 653,28 0,39%